HomeAuthorsPosts by Sam Atkinson

Sam Atkinson

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge in profit for the third quarter ended May 31, 2026. This performance marks a decisive shift from a period of recovery toward a new phase of resilient growth in the...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the country grapples with a growing burden of non-communicable diseases (NCDs), particularly diabetes and chronic kidney disease. Recent estimates show that one-in-six Malaysians has diabetes, while one-in-seven is at risk of chronic...
spot_img

Keep exploring

SGX-LISTED COMPANIES

Khong Guan Limited’s FY2025 Operations Hit By Doubtful Debts

This Company Issued a Profit Warning. The Real Story is More Interesting Introduction: Beyond the...
SGX-LISTED COMPANIES

How Adverse Market Conditions Impacted Jawala Inc.’s FY2025 Performance

We Read a 25-Page Financial Report So You Didn't Have To. Here Are 4...
SGX-LISTED COMPANIES

F J Benjamin Holdings Sees Net Loss Widen Drastically In FY2025

5 Surprising Truths Hidden in a Fashion Retailer's Financial Report Corporate financial reports have a...
SGX-LISTED COMPANIES

How Growth Concealed Vicplas International’s Massive Loss In FY2025

This Company's Revenue Grew 13%—Here's Why It's Losing More Money Than Ever In the world...
SGX-LISTED COMPANIES

Southern Alliance Mining’s FY2025 Loss Skyrockets 1,157%

This Mining Company's Revenue Grew 20%, But Losses Exploded Over 1,000%. Here’s What’s Really...
SGX-LISTED COMPANIES

Uni-Asia Group Reverses $12 Million Loss In 2025 First Half

From Collision to Profitability: The Surprising Turnaround Inside Uni-Asia's Latest Financial Report Corporate financial reports...
SGX-LISTED COMPANIES

Amova SGD Investment Grade Corporate Bond ETF Shows Singapore Bonds Beat Expectations In 2025

We Read a 36-Page Bond Fund Report. Here Are the 5 Most Surprising Things...
SGX-LISTED COMPANIES

What Caused A-Smart Holdings Print Business To Plummet In Full Year 2025

4 Surprising Takeaways From A Tiny Company's Big Bet on an Emerging Nation Corporate financial...
SGX-LISTED COMPANIES

Amova-StraitsTrading Asia Ex Japan REIT ETF Reports Huge Performance Swing In 2025

4 Eye-Opening Truths Hidden in a REIT ETF's Annual Report Introduction Many of us invest in...
SGX-LISTED COMPANIES

How The Amova Singapore STI ETF Achieved A 24.92% Return In 2025

What's Really Inside Your Singapore STI ETF? 5 Surprising Facts From the Annual Report Introduction:...
SGX-LISTED COMPANIES

Amova ABF Singapore Bond Index Fund Reports Strong 10.61% Returns In 2025

We Read a 50-Page Bond Fund Report So You Don’t Have To. Here Are...
SGX-LISTED COMPANIES

Why AI Is Changing Everything For Sunright Limited In FY2025

This Tech Company Lost Millions Amid an AI Boom. Here Are 4 Surprising Reasons...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...